Mouse anti Human Cytochrome p450 26A1

Mouse anti Human Cytochrome p450 26A1, Monoclonal, IgG2b, Clone: F27 P6 A1
Artikelnummer
EXAX2049M
Verpackungseinheit
200 µg
Hersteller
Exalpha Biologicals Inc

Verfügbarkeit: wird geladen...
Preis wird geladen...
Clone: F27 P6 A1

Background: The cytochrome P450 proteins (CYPs) are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. P450 enzymes are classified into subfamilies based on their sequence similarities. CYP26A1, also referred to as retinoic acid-4-hydroxylase, is a major retinoic acid catabolic enzyme. CYP26A1 plays an important role in protecting tailbud tissues from inappropriate exposure to retinoic acid. CYP26A1 transcription is epigenetically regulated by nuclear retinoic acid receptors 2. Mutations in the gene encoding for CYP26A1 are associated with caudal agenesis and spina bifida, imperforate anus, agenesis of the caudal portions of the digestive and urogenital tracts, and malformed lumbosacral skeletal elements. CYP26A1 is upregulated in adenomatous polyposis coli mouse adenomas, human FAP adenomas, human sporadic colon carcinomas, and in the intestine of adenomatous polyposis coli(mcr) mutant zebrafish embryos.

Positive Control: Liposarcoma cells

Immunogen: Hybridoma produced by the fusion of splenocytes from BALB/c mice immunized with a synthetic peptide derived from the C-terminus of the human CYP450 26A1 protein and mouse myeloma Ag8563 cells.

Purification Method: Protein A/G Chromatography

Concentration: See vial for concentration

Formulation: Provided as solution in phosphate buffered saline with 0.08% sodium azide

References: 1. Kumarakasingham, M., et al. (2005). Cytochrome p450 profile of colorectal cancer: Identification of markers of prognosis. Clin. Cancer Res. 11(10);3758-3765.2. Sakai, Y., et al. (2004). CYP26A1 and CYP26C1 cooperate in degrading retinoic acid within the equatorial retina during later eye development. 276(1);143-1573. Osanai, M. and Petkovich, M. (2005). Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death. 67(5);1808-1817

UniProt: O43174 (Human)

Caution: This product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals.
Mehr Informationen
Artikelnummer EXAX2049M
Hersteller Exalpha Biologicals Inc
Hersteller Artikelnummer X2049M
Verpackungseinheit 200 µg
Mengeneinheit STK
Reaktivität Human
Klonalität Monoclonal
Methode Western Blotting, Immunohistochemistry
Isotyp IgG2b
Wirt Mouse
Konjugat Unconjugated
Produktinformation (PDF) Download
MSDS (PDF) Download